High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement

References

• Bingley PJ, Gale EAM. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: The role of additional immune, genetic and metabolic markers of risk. Diabetologia. 2006; 49:881–890.
   PubMed Web of Science ®Google Scholar
• Schranz DB, Lernmark A. Immunology in diabetes: An update. Diabetes Metab Rev. 1998; 14:3–29.
   PubMed Web of Science ®Google Scholar
• Wasserfall CH, Atkinson MA. Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun Rev. 2006; 5 6: 424–428.
   PubMed Web of Science ®Google Scholar
• Lernmark A. Glutamic acid decarboxylase—Gene to antigen to disease. J Intern Med. 1996; 240:259–277.
   PubMed Web of Science ®Google Scholar
• Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B. TEDDY—The environmental determinants of diabetes in the young: An observational clinical trial. Ann N Y Acad Sci. 2006; 1079:320–326.
   PubMed Web of Science ®Google Scholar
• Desai M, Clark A. Autoimmune diabetes in adults: Lessons from the UKPDS. Diabetic Med. 2008; 25:30–34.
   PubMed Web of Science ®Google Scholar
• Castleden HAJ, Shields B, Bingley PJ, Williams AJK, Sampson M, Walker M, Gibson JM, McCarthy MI, Hitman GA, Levy JC, Hattersley AT, Vaidya B, Pearson ER. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes. Diabetic Med. 2006; 23:834–838.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Oak S, Shimada A, Hampe CS. GAD65 Autoantibody responses in Japanese latent autoimmune diabetes in adult patients. Diabetes Care. 2008; 31:1602–1607.
   PubMed Web of Science ®Google Scholar
• Gilliam LK, Palmer JP. Latent autoimmune diabetes in adults. Insulin. 2006; 1:122–127.
   Google Scholar
• Huriya B, Thomas O, David R, Leslie G. progression of autoimmune diabetes: Slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult. Ann N Y Acad Sci. 2006; 1079:81–89.
   PubMed Web of Science ®Google Scholar
• Juneja R, Palmer JP. Type 1 1/2 diabetes: Myth or reality?. Autoimmunity. 1999; 29:65–83.
   PubMed Web of Science ®Google Scholar
• Gilliam LK, Binder KA, Banga JP, Madec AM, Ortqvist E, Kockum I, Luo D, Hampe CS. Multiplicity of the antibody response to GAD65 in Type I diabetes. Clin Exp Immunol. 2004; 138:337–341.
   PubMed Web of Science ®Google Scholar
• Fenalti G, Hampe CS, O'Connor K, Banga JP, Mackay IR, Rowley MJ, El-Kabbani O. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11. Mol Immunol. 2007; 44:1178–1189.
   PubMed Web of Science ®Google Scholar
• Hampe CS, Lundgren P, Daniels TL, Hammerle LP, Marcovina SM, Lernmark A. A novel monoclonal antibody specific for the N-terminal end of GAD65. J Neuroimmunol. 2001; 113:63–71.
   PubMed Web of Science ®Google Scholar
• Schlosser M, Banga JP, Madec AM, Binder KA, Strebelow M, Rjasanowski I, Wassmuth R, Gilliam LK, Luo D, Hampe CS. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk for developing type 1 diabetes. Diabetologia. 2005; 48:922–930.
   PubMed Web of Science ®Google Scholar
• Hampe CS, Kockum I, Landin-Olsson M, Törn C, Ortqvist E, Persson B, Rolandsson O, Palmer J, Lernmark A. GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes. Diabetes Care. 2002; 25 8: 1481–1482.
   PubMed Web of Science ®Google Scholar
• Daka B, Svensson MK, Lernmark A, Mincheva-Nilsson L, Hallmans G, Rolandsson O. Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes. Autoimmunity. 2009; 42:507–514.
   PubMed Web of Science ®Google Scholar
• Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 1994; 37 4: 344–350.
   PubMed Web of Science ®Google Scholar
• Falorni A, Ortqvist E, Persson B, Lernmark A. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Meth. 1995; 186 1: 89–99.
   PubMed Web of Science ®Google Scholar
• Sohnlein P, Müller M, Syren K, Hartmann U, Bohm BO, Meinck HM, Knip M, Akerblom HK, Richter W. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. Diabetologia. 2000; 43:210–217.
   PubMed Web of Science ®Google Scholar
• Franks PW, Rolandsson O, Debenham SL, Fawcett KA, Payne F, Dina C, Froguel P, Mohlke KL, Willer C, Olsson T, Wareham NJ, Hallmans G, Barroso I, Sandhu MS. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia. 2008; 51:523.
   Web of Science ®Google Scholar
• Richter W, Eiermann TH, Endl J, Seissler J, Wolfahrt S, Brandt M, Jungfer H, Scherbaum WA. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies. Diabetologia. 1993; 36 8: 785–790.
   PubMed Web of Science ®Google Scholar
• Bonifacio E, Lernmark A, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Meth. 1988; 106 1: 83–88.
   PubMed Web of Science ®Google Scholar
• Mire-Sluis AR, Gaines Das R, Lernmark A. The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia. 2000; 43 10: 1282–1292.
   PubMed Web of Science ®Google Scholar
• Olsson ML, Sundkvist G, Lernmark A. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987; 30 5: 327–332.
   PubMed Web of Science ®Google Scholar
• Solimena M, De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 1991; 14 10: 452–457.
   PubMed Web of Science ®Google Scholar
• Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, Holmøy T. GAD65 IgG autoantibodies in stiff person syndrome: Clonality, avidity and persistence. Eur J Neurol. 2008; 15:973–980.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen,Ovanliga Diagnoser, Stiff Person Syndrome [Internet], Available at: www.socialstyrelsen.se/ovanligadiagnoser/Stiff+person+syndrome.
   Google Scholar